“We don’t comment on marketplace rumor."

Pharma company Pfizer is purportedly trying to buy rival Wyeth for $60 billion dollars, but a Wyeth spokesman refuses to comment.

“I think we are seeing a funding future that is a reflection of the world’s current economy.”

Jules Duga has co-authored a report suggesting that the US will spend less on R&D in 2009, the first decrease in a decade.

Anti-evolution biologist has his court case against his old bosses dismissed, again.

An appeals court has upheld a ruling that Nathaniel Abraham’s lawsuit, claiming he was asked to resign from Woods Hole Oceanographic Institute for telling his supervisor that he didn’t believe in evolution, was not filed in time.

“Our goal is to develop, form and finance one or two companies a year.”

Johnson & Johnson is the latest member to join a global consortium of pharma companies that will fund research together and co-own the results, says Daphne Zohar, founder of PureTech. The total in the pot is now $52 million.